Who owns ARCH Venture Fund X, L.P.?

No ownership or control links for ARCH Venture Fund X, L.P. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is ARCH Venture Fund X, L.P.'s risk level?

WhiteIntel flags ARCH Venture Fund X, L.P. as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does ARCH Venture Fund X, L.P. appear across sources?

ARCH Venture Fund X, L.P. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage

●

ARCH Venture Fund X, L.P.

Name: ARCH Venture Fund X, L.P. — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, ARCH Venture Fund X, L.P., Person, US

LowPersonUS

controls 7 companies

The finding

Controls or directs 7 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

View network

JSON / MCPsample

Markdown twin

/01

Registry identity

Controls: 7 companies
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

ARCH Venture Fund X, L.P.
- Maze Therapeutics, Inc.· 10% owner· via SEC EDGAR (Form 3/4/5)
- Neumora Therapeutics, Inc.· tenpercentowner· via SEC EDGAR
- Prime Medicine, Inc.· tenpercentowner· via SEC EDGAR
- Sana Biotechnology, Inc.· tenpercentowner· via SEC EDGAR
- Erasca, Inc.· tenpercentowner· via SEC EDGAR
- Verve Therapeutics, Inc.· tenpercentowner· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for ARCH Venture Fund X, L.P. — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of ARCH Venture Fund X, L.P. is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE4

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

BEHIND THE GLASS1

Full export (PDF + un-redacted JSON) & change alertsPREMIUM

/03

People & control

6 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
Erasca, Inc.
Also holds roles at 33 other companies
- Garner Ebunofficer
- Chacko David M.officer
- Morris Shannonofficer
●
Maze Therapeutics, Inc.
Also holds roles at 48 other companies
- Third Rock Ventures IV, L.P.10% owner
- Third Rock Ventures GP IV, L.P.10% owner
- Third Rock Ventures GP V, LP10% owner
●
Neumora Therapeutics, Inc.
Also holds roles at 36 other companies
- BERNS PAUL Lofficer
- Milligan Michael Leeofficer
- Aurora Daljit Singhofficer
●
Prime Medicine, Inc.
Also holds roles at 45 other companies
- Gottesdiener Keith Michaelofficer
- Alenson Carmanofficer
- Goldwasser Meredithofficer
●
Sana Biotechnology, Inc.
Also holds roles at 51 other companies
- Wyrick Susan D.officer
- Cassidy Bernard Jofficer
- Harr Steveofficer
●
Verve Therapeutics, Inc.
Also holds roles at 76 other companies
- Dorval Allisonofficer
- Kathiresan Sekarofficer
- Lister Troyofficer

6 parties · 0 current. Ceased and resigned records are retained as history.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on ARCH Venture Fund X, L.P.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…